Institute of Molecular and Cell Biology (IMCB)
Going with the Met-Flow
22 Feb 2021Researchers now have the tools to analyze the unique metabolic protein signatures of diverse immune cell subpopulations in different states of activation.
Making a mark on stem cell therapy
17 Feb 2021A novel genomic biomarker may help to meet the demand for donor mesenchymal stem cells in regenerative medicine.
A collagen ‘highway’ for cancer
1 Feb 2021The structure of collagen fibers may play a key role in the spread of breast cancer, with implications for clinical prognosis and treatment.
A rosy view of malaria research
28 Jan 2021Flower-like ‘rosettes’ may help malaria parasites evade the body’s immune defences.
A tough choice for embryo cells
25 Jan 2021Keratin, a tough and insoluble fibrous protein, plays a surprising role in determining mouse embryonic cell fate.
Shedding light on Alzheimer’s disease
21 Jan 2021By selectively switching on neurons with light, scientists can piece together crucial events in Alzheimer’s disease progression.
Meet the class of 2021
21 Dec 2020Three A*STAR scholars—Sarah Luo, Caroline Wee, and Kaicheng Liang—have been selected for the highly competitive National Research Foundation Fellowship out of over 134 applicants worldwide.
Commemorating outstanding science and excellent scientists
18 Dec 2020From genomics to gene editing and cancer research, the A*STAR winners of the 2020 President’s Science and Technology Awards and Young Scientist Awards are blazing the trail in biological research.
Accelerating malaria drug discovery
23 Nov 2020A new method of identifying drug targets in the malaria parasite P. falciparum could find broad applications in other fields of biology.
Turning cancer against itself
18 Nov 2020Exploiting a mutation in a key tumor-fighting protein may provide a new opportunity to treat aggressive lung cancers.
Pressing pause on DNA damage
16 Nov 2020A protein known to switch on DNA repair genes also ‘pauses’ the cell cycle in response to DNA damage, A*STAR researchers find.
Assuring asymptomatic COVID-19 carriers are identified
6 Nov 2020A*STAR researchers have developed a point-of-care rapid antibody test kit that can detect antibodies produced in response to SARS-CoV-2 infection in just fifteen minutes.